Medication adherence and management of risk factors for secondary stroke prevention
- Conditions
- Cerebral infarction,
- Registration Number
- CTRI/2022/06/042980
- Lead Sponsor
- World Stroke Organization
- Brief Summary
This study aims to develop a smart phone based personal monitoring app among stroke survivors to improve adherence to the medication, control of vascular risk factors, provide health education and physician involvement. Phase 1 of the study will be development of mobile app using Qualitative -Delphi method and phase 2 will be a randomized controlled trial designed to determine the feasibility of using this app in hospital setting for secondary stroke prevention. One hundred and ninety-two (n=192) adult patients with onset of stroke within 1 month will be randomized into intervention and control arm. The primary outcome will be assessed as medication adherence and control of vascular risk factors. The secondary outcome will be Vascular events namely TIA/Stroke/Cardiac events/Vascular deaths, functional outcome which will be assessed by mRS. The follow up will be done at the baseline, 3 month and 6 month. The data will be analyzed using appropriate statistical measures to determine efficacy of the mobile app in secondary prevention of stroke.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 192
- 1.Adult (>18 years) patients with onset of stroke within 1 month.
- 2.Severity :- mRs<5 3.Presence of one or more vascular risk factors such as hypertension, diabetes mellitus, smoking and dyslipidemia.
- 4.Patient/caregivers who could fully understand the use of an Android-based smartphone.
- 1.Patients with severe disability -modified Rankin Scale score>4 2.Patients who do not consent.
- 3.Severe cognitive impairment.
- 4.Stroke survivor without a primary caregiver.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Medication adherence is defined as consumption of at least more than 80% of their medications for the last two weeks based on the last prescription. Baseline, Three months and Six months 2. Control of vascular risk factors Baseline, Three months and Six months
- Secondary Outcome Measures
Name Time Method 1. Vascularevents-TIA/Stroke/Cardiac events/Vascular deaths 2. Functional outcome-assessed by mRS
Trial Locations
- Locations (1)
Sree Chitra Tirunal Institute for Medical Sciences and Technology
🇮🇳Thiruvananthapuram, KERALA, India
Sree Chitra Tirunal Institute for Medical Sciences and Technology🇮🇳Thiruvananthapuram, KERALA, IndiaDr P N SylajaPrincipal investigator9446566287sylajapn@hotmail.com